- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Scopus BioPharma (NASDAQ:SCPS), Quotes and News Summary
Scopus BioPharma (NASDAQ: SCPS)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-12 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-06-03 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Scopus BioPharma Questions & Answers
You can purchase shares of Scopus BioPharma (NASDAQ: SCPS) through any online brokerage.
Other companies in Scopus BioPharma’s space includes: Plus Therapeutics (NASDAQ:PSTV), Allena Pharma (NASDAQ:ALNA), PolarityTE (NASDAQ:PTE), Benitec Biopharma (NASDAQ:BNTC) and Histogen (NASDAQ:HSTO).
The latest price target for Scopus BioPharma (NASDAQ: SCPS) was reported by Benchmark on Tuesday, February 16, 2021. The analyst firm set a price target for 20.00 expecting SCPS to rise to within 12 months (a possible 4292.71% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Scopus BioPharma (NASDAQ: SCPS) is $0.4553 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for Scopus BioPharma.
Scopus BioPharma’s Q2 earnings are confirmed for Friday, August 12, 2022.
There is no upcoming split for Scopus BioPharma.
Scopus BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.